Dr. Richard Baird

Cancer Research UK Cambridge Centre

Dr. Baird is an academic medical oncologist at the Cancer Research UK Cambridge Centre. He has established a portfolio of early phase clinical trials available to breast cancer patients in the East of England and beyond. There is a high proportion of investigator-initiated studies - some run from Cambridge and others run by collaborators across the UK. He has particular research interests in: precision medicine trials / matched molecular therapies; the development of liquid biopsies to improve treatment selection; novel drug-radiotherapy combinations; and in novel therapeutic strategies for patients with brain metastases.

dont miss

Update on Precision Medicine Approaches to Treat Metastatic Breast Cancer

In recent decades, tremendous progress has been made in understanding the molecular basis of breast cancer. For some cancer subtypes, targets have been identified which - when treated with the right targeted therapy - have yielded major improvements in clinical outcomes for patients. Dr. Baird will discuss current precision medicine approaches to the treatment of metastatic breast cancer, taking into account the challenges of cancer heterogeneity and drug resistance.

EVEN MORE SEMINARS

  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention

  • Rob Duncombe: Speaking at the Oncology Convention

    Rob Duncombe
    The Christie NHS Foundation Trust

    Medicine Optimisation in Oncology. How to achieve best value.

  • Nirmesh Patel: Speaking at the Oncology Convention

    Nirmesh Patel
    Cambridge Cancer Genomics

    Monitoring cancer evolution through smart genomics and liquid biopsies